29^th European Nephrology Conference

Pharmacogenomics and Personalized Medicine in Renal Therapeutics

Pharmacogenomics and personalized medicine are revolutionizing renal therapeutics by tailoring drug treatments to individual genetic profiles, optimizing efficacy, and minimizing adverse effects. Pharmacogenomics studies how genetic variations influence drug metabolism, efficacy, and toxicity, allowing for more precise prescribing practices. For renal patients, this means medications can be selected and dosed based on genetic markers that predict responses to drugs commonly used in kidney disease management. Personalized medicine further enhances this approach by integrating genetic information with patient-specific factors such as lifestyle and health conditions, enabling individualized treatment plans. This is particularly valuable for managing chronic kidney disease, hypertension, and diabetes, where drug interactions and side effects can be significant. By using genetic insights to guide therapy, pharmacogenomics aims to improve therapeutic outcomes, reduce trial-and-error prescribing, and enhance overall patient safety in renal care.